Physician

James J Rooney, M.D.

According to 2025 Medicare claims, James Rooney, M.D. (NPI: 1215983358) practices hematology/oncology in the Worcester, MA market, with the plurality of this provider's patient population coming from Worcester, MA. This provider's primary affiliated billing organization is RELIANT MEDICAL GROUP, INC (NPI: 1720017528; TIN: 042472266) and primary practice location at 01606-2714. Rooney is affiliated with the Reliant Medical Group, Inc. (ACO ID: D0218), participating under the REACH model.

Rooney's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 367 traditional Medicare patients, billed 89,910 HCPCS/CPT codes, and received $1,329,118 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 1,100 prescription claims across 193 beneficiaries totaling $1,643,988 in drug costs, led by Revlimid (Lenalidomide). 2022 DME data shows 33 claims. Open Payments data shows 14 records totaling $1,625. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $85,384 to $1,329,118. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $905 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	315	4,442	$85,384
2016	338	6,803	$124,560
2017	364	22,571	$167,931
2018	361	24,332	$136,213
2019	328	4,713	$171,447
2020	326	5,071	$179,677
2021	383	44,734	$813,267
2022	421	67,409	$959,047
2023	359	82,805	$1,385,909
2024	367	89,910	$1,329,118

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	231	1,214	$805,097
2016	258	1,447	$1,689,654
2017	293	1,469	$2,252,274
2018	269	1,491	$2,678,479
2019	268	1,346	$2,621,033
2020	245	1,237	$2,859,306
2021	249	1,204	$2,825,519
2022	229	1,124	$2,232,876
2023	195	1,009	$1,733,481
2024	193	1,100	$1,643,988

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	55	$26,341
2016	N/R	35	$34,433
2017	N/R	33	$25,873
2018	N/R	N/R	N/R
2019	N/R	13	$245
2020	N/R	N/R	N/R
2021	N/R	11	$1,404
2022	N/R	33	$1,119
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96413	Administration of chemotherapy into vein, 1 hour or less	59	191	$106
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	142	305	$92
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	104	186	$49
96366	Infusion into a vein for therapy, prevention, or diagnosis, each additional hour	36	73	$16
96375	Injection of additional new drug or substance into vein	70	325	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	20	560	$344,680
Lumakras	Sotorasib	11	330	$219,678
Lenalidomide	Lenalidomide	16	448	$184,513
Calquence	Acalabrutinib Maleate	14	420	$175,422
Abiraterone Acetate	Abiraterone Acetate	46	1,348	$81,201

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	12	$356	Eisai Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	2	$1,269	Eli Lilly and Company
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for James J. Rooney, M.D.?

Tedicare shows public-source Medicare data for James J. Rooney, M.D. (NPI 1215983358), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James J. Rooney, M.D. have ACO affiliation data?

James J. Rooney, M.D. is shown with ACO affiliation data for Reliant Medical Group, Inc. (REACH, ACO ID D0218).

What billing organization is linked to James J. Rooney, M.D.?

James J. Rooney, M.D. is linked to RELIANT MEDICAL GROUP, INC (billing NPI 1720017528) in the available physician profile data.

Does James J. Rooney, M.D. have Open Payments data?

James J. Rooney, M.D. has 14 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.